药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ranibizumab
Isavuconazole
Isavuconazole may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Vemurafenib
Vemurafenib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Fedratinib
Fedratinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Nabiximols
Nabiximols may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Estradiol valerate
Estradiol valerate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Estradiol dienanthate
Estradiol dienanthate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Estradiol cypionate
Estradiol cypionate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Estradiol benzoate
Estradiol benzoate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Estradiol acetate
Estradiol acetate may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Gilteritinib
Gilteritinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Fostamatinib
Fostamatinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Avatrombopag
Avatrombopag may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Glasdegib
Glasdegib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Baricitinib
Baricitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Dasabuvir
Dasabuvir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Olaparib
Olaparib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Palbociclib
Palbociclib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Cannabidiol
Cannabidiol may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Teriflunomide
Teriflunomide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Ubidecarenone
The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pitavastatin.